Paper55892
Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.
Powles TJ and 4 others. Lancet, 1976. Cited by 115 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Papers, record 55892. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55892
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aspirin | Major topic |
| Bone Neoplasms | Major topic |
| Bone Resorption | Major topic |
| Breast Neoplasms | Major topic |
| Neoplasm Metastasis | Major topic |
| Osteolysis | Major topic |
| Animals | |
| Bone and Bones | |
| Calcium | |
| Culture Techniques | |
| Cyclooxygenase Inhibitors | |
| Female | |
| Humans | |
| Hypercalcemia | |
| Mice | |
| Paraneoplastic Endocrine Syndromes |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,099,932 | Aspirin and cancer: biological mechanisms and clinical outcomes. | Open Biol | 2022 | https://conductscience.org/library/papers/36099932 | PubMed |
| 34,485,279 | miRNA-7062-5p Promoting Bone Resorption After Bone Metastasis of Colorectal Cancer Through Inhibiting GPR65. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34485279 | PubMed |
| 30,461,194 | Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/30461194 | PubMed |
| 27,303,926 | Molecular and genetic inflammation networks in major human diseases. | Mol Biosyst | 2016 | https://conductscience.org/library/papers/27303926 | PubMed |
| 24,140,083 | Targeting tumor-stromal interactions in bone metastasis. | Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24140083 | PubMed |
| 23,388,178 | Non-steroid anti-inflammatory drugs, prostaglandins, and cancer. | Cell Biosci | 2013 | https://conductscience.org/library/papers/23388178 | PubMed |
| 22,439,092 | Metastatic spinal tumor. | Asian Spine J | 2012 | https://conductscience.org/library/papers/22439092 | PubMed |
| 8,347,847 | Mechanisms involved in the metastasis of cancer to bone. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/8347847 | PubMed |
| 7,773,580 | The management of hypercalcemia of malignancy. | Support Care Cancer | 1995 | https://conductscience.org/library/papers/7773580 | PubMed |
| 7,470,384 | In vitro osteolytic activity of human breast carcinoma tissue and prognosis. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7470384 | PubMed |
| 7,383,949 | Hypercalcaemia in malignant lymphoma. | Postgrad Med J | 1980 | https://conductscience.org/library/papers/7383949 | PubMed |
| 7,370,160 | Prostaglandin-like material extracted from squamous carcinomas of the head and neck. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7370160 | PubMed |
| 7,216,714 | Differentiation of hypercalcaemia due to malignancy from primary hyperparathyroidism: the value of parathyroid hormone and plasma bicarbonate measurements. | Ir J Med Sci | 1981 | https://conductscience.org/library/papers/7216714 | PubMed |
| 7,104,197 | Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7104197 | PubMed |
| 6,688,732 | Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6688732 | PubMed |
| 6,580,033 | Further observations on mechanisms of bone destruction by squamous carcinomas of the head and neck: the role of host stroma. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6580033 | PubMed |
| 3,859,318 | Prostaglandin F2 alpha in benign and malignant breast tumours. | Br J Cancer | 1985 | https://conductscience.org/library/papers/3859318 | PubMed |
| 3,855,865 | Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells. | J Clin Invest | 1985 | https://conductscience.org/library/papers/3855865 | PubMed |
| 3,593,988 | Inhibition by indomethacin of spontaneous mammary tumorigenesis in SHN mice. | Breast Cancer Res Treat | 1986 | https://conductscience.org/library/papers/3593988 | PubMed |
| 3,094,242 | Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas. | Virchows Arch A Pathol Anat Histopathol | 1986 | https://conductscience.org/library/papers/3094242 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/55892
GET https://conductscience.org/api/papers/v1/55892/cited_by?page=2